Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial - Archive ouverte HAL Access content directly
Journal Articles European Journal of Cancer Year : 2018

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial

(1) , , , , , , (2) , , (3) , (4) , , , (5) , (6) , , , , , (7) , , , , ,
1
2
3
4
5
6
7
B. Weenink
  • Function : Author
M. van den Bent
  • Function : Author
L. Erdem-Eraslan
  • Function : Author
M. Kros
  • Function : Author
Pae Sillevis Smitt
  • Function : Author
A. Brandes
  • Function : Author
R. Enting
  • Function : Author
G.F. Ryan
  • Function : Author
O. Chinot
M.E. van Linde
  • Function : Author
W.P. Mason
  • Function : Author
J.M.M. Gijtenbeek
  • Function : Author
C. Balana
  • Function : Author
Th Gorlia
  • Function : Author
R. Stupp
  • Function : Author
M.E. Hegi
  • Function : Author
B.G. Baumert
  • Function : Author
P.J. French
  • Function : Author
Not file

Dates and versions

hal-01814360 , version 1 (13-06-2018)

Identifiers

Cite

Y. Gao, B. Weenink, M. van den Bent, L. Erdem-Eraslan, M. Kros, et al.. Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial. European Journal of Cancer, 2018, 94, pp.168 - 178. ⟨10.1016/j.ejca.2018.02.023⟩. ⟨hal-01814360⟩
20 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More